Related references
Note: Only part of the references are listed.Nuclear Exclusion of p33ING1b Tumor Suppressor Protein: Explored in HCC Cells Using a New Highly Specific Antibody
Berna Sayan et al.
HYBRIDOMA (2009)
Nuclear translocation of active AKT is required for erythroid differentiation in erythropoietin treated K562 erythroleukemia cells
Silvia Missiroli et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Dysregulation of apoptosis in hepatocellular carcinoma cells
Isabel Fabregat
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
Deregulation of the Akt pathway in human cancer
Eriko Tokunaga et al.
CURRENT CANCER DRUG TARGETS (2008)
The PI3K/Akt pathway: Recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors
Craig W. Lindsley et al.
CURRENT CANCER DRUG TARGETS (2008)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection
Klaus Juergen Schmitz et al.
JOURNAL OF HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Inhibition of mammalian target of rapamycin signaling by 2-(Morpholin-1-yl) pyrimido[2,1-α]isoquinolin-4-one
Lisa M. Ballou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications
Alexandre Arcaro et al.
CURRENT GENOMICS (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
NF-kappa B signaling and carcinogenesis
Takashi Okamoto et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Hypoxia-induced cell death of HepG2 cells involves a necrotic cell death mediated by calpain
Min-Ju Kim et al.
APOPTOSIS (2007)
Live cell quality control and utility of real-time cell electronic sensing for assay development
Shelli L. Kirstein et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2006)
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
M Cully et al.
NATURE REVIEWS CANCER (2006)
Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells
N Ozturk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Lithium-mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells
E Erdal et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Discovery of 2,3,5-trisubstituted pyridine derivatives as potent AM Akt1 and Akt2 dual inhibitors
ZJ Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma
K Nakanishi et al.
CANCER (2005)
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors
SF Barnett et al.
BIOCHEMICAL JOURNAL (2005)
Structure, regulation and function of PKB/AKT - a major therapeutic target
M Hanada et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)
PI3K-Akt pathway: Its functions and alterations in human cancer
M Osaki et al.
APOPTOSIS (2004)
Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma
TH Hu et al.
CANCER (2003)
International trends and patterns of primary liver cancer
KA McGlynn et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases
S Gobeil et al.
CELL DEATH AND DIFFERENTIATION (2001)